Emerging studies suggest Retatru tide , a dual activator targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , appears to offer a promising development for weight management . Initial clinical trials have demonstrated considerable losses in abdominal mass , conceivably exceeding existing weight-loss therapies . Despit